This company has lost its way - Sales Cytel Inc Employee Review

3.0
4 Dec 2022
Recommend
CEO approval
Business outlook

Pros

Excellent strength in biostatistics Founder, Prof. Cyrus Mehta is considered thought leader in adaptive design EAST is primary software used for complex, adaptive statistical clinical trial design - used everywhere including FDA

Cons

The company has lost its way. Treatment of staff can be impersonal. It can be a treadmill for stats programmers like many other larger CROs. Original culture is lost and it has become another Parexel for better or worse. Numerous key people have left under current leadership. CEO is hard-charging, without a coherent technology vision and too willing to treat people as commodities rather than core of the business.

Explore other reviews about Cytel Inc

5.0
16 Jan 2026
Recommend
CEO approval
Business outlook

Pros

Supportive and invested leadership team

Cons

Few opportunities for FTE in data management

2.0
23 Oct 2025
Recommend
CEO approval
Business outlook

Pros

- Competitive compensation - Opportunity to work with a variety of pharmaceutical clients - Exposure to a wide spectrum of projects in real-world evidence (RWE)

Cons

- Toxic work culture prevalent across multiple RWE (RWAA) teams, where focus is often on internal politics, job security, and profit rather than collaboration and integrity - Teams frequently prioritize client appeasement over objective assessment and scientific rigor - Disproportionate emphasis/value on document formatting and presentation instead of the substance and quality of scientific work, making roles feel clerical rather than analytical - The RWE department, in particular, appears to have lost clear direction and purpose

See reviews by: Helpful|Rating|Date|All